01.12.2012 Views

Fiscal Year 2007 - Department of Medicine - University of ...

Fiscal Year 2007 - Department of Medicine - University of ...

Fiscal Year 2007 - Department of Medicine - University of ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

70<br />

Sponsor and Title: HRSA, “The Delta Telehealth<br />

Partnership”<br />

Principal Investigator: Marshall J. Bouldin<br />

Project Period: 09/01/2005-08/31/<strong>2007</strong><br />

Annual Funding: $272,184<br />

Sponsor and Title: McKesson Health Solutions,<br />

“Cooperative Agreement for a Medicare Fee-For-<br />

Service Chronic Care Improvement”<br />

Principal Investigator: Marshall J. Bouldin<br />

Project Period: 05/05/2006-04/31/2008<br />

Annual Funding: $1,277,500<br />

Sponsor and Title: Mississippi State <strong>Department</strong><br />

<strong>of</strong> Health, “Diabetes Control Program”<br />

Principal Investigator: Marshall J. Bouldin<br />

Project Period: 01/01/2006-12/31/2006<br />

Annual Funding: $50,000<br />

Sponsor and Title: NorvoNordisk, “Sugar in the<br />

Delta: Culture and Disease”<br />

Principal Investigator: Marshall J. Bouldin<br />

Project Period: 04/06/2006-3/31/<strong>2007</strong><br />

Annual Funding: $30,000<br />

Sponsor and Title: AHRQ, “Addressing Preventable<br />

Medication Use Variance in Mississippi”<br />

Principal Investigator: C. Andrew Brown<br />

Project Period: 08/01/2001-09/01/2006<br />

Annual Funding: $142,557<br />

Sponsor and Title: AHRQ, “Detecting Medical<br />

Errors in Rural Hospitals Using Technology”<br />

Principal Investigator: C. Andrew Brown<br />

Project Period: 09/01/2004-8/31/<strong>2007</strong><br />

Annual Funding: $542,011<br />

Sponsor and Title: AHRQ, “Preventable Medication<br />

Use Variance in Mississippi (Minority Supplement)”<br />

Principal Investigator: C. Andrew Brown<br />

Project Period: 09/30/2001-09/30/2006<br />

Annual Funding: $76,280<br />

Sponsor and Title: Bristol-Myers Squibb, “Genital<br />

Ulcer Disease: A Risk Factor for Hepatitis C<br />

virus and Human Immunodeficiency Virus”<br />

Principal Investigator: Mary Jane Burton<br />

Project Period: 10/01/2005-09/30/2008<br />

Annual Funding: $15,000<br />

Sponsor and Title: Merck and Co., Inc., “Non<br />

ICU Surveillance Study: Incidence <strong>of</strong> Multiresistance<br />

in Serial Gram-Negative Isolates”<br />

Principal Investigator: Stanley W. Chapman<br />

Project Period: 07/1/2005-06/15/<strong>2007</strong><br />

Annual Funding: $7,000<br />

Sponsor and Title: HHS, “SWOG Clinical Research<br />

Associates Chair”<br />

Principal Investigator: Debbie Christie<br />

Project Period: 03/01/2006-02/28/<strong>2007</strong><br />

Annual Funding: $10,284<br />

Sponsor and Title: Research Mississippi Inc.<br />

“Cancer Clinical Trials”<br />

Principal Investigator: Minsig Choi<br />

Project Period: 02/01/<strong>2007</strong>-01/31/2008<br />

Annual Funding: $25, 000<br />

Sponsor and Title: Adventrx Pharmaceuticals,<br />

Inc., “A Phase III Multi-Center Randomized Clinical<br />

Trial to Evaluate the Safety and Efficacy <strong>of</strong><br />

CoFactor and 5-Fluorouracil (5-FU) plus Bevacizumab<br />

versus Leucovorin and 5-FU plus Bevacizumab<br />

as Initial Treatment for Metastatic<br />

Colorectal Carcinoma ”<br />

Principal Investigator: Minsig Choi<br />

Project Period: 04/03/<strong>2007</strong>-12/01/2009<br />

Annual Funding: $453,575<br />

Sponsor and Title: NIAID, “High Purity Amphotericin<br />

B: A Safer Antimycotic in AIDS”<br />

Principal Investigator: John Cleary<br />

Project Period: 04/01/2005-/03/31/<strong>2007</strong><br />

Annual Funding: $110,664

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!